IVF Stock Analysis: Buy, Sell, or Hold?
IVF - INVO Fertility, Inc. Common Stock
$2.68
2.10 (364.47%)
▲
5d:
+288.29%
30d:
+179.81%
90d:
+206.43%
WAIT
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Apr 29, 2026
29d
Get Alerted When IVF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: IVF is 176.3% above fair value ($0.97). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: IVF is 176.3% above fair value ($0.97). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: IVF is currently trading at $2.68, which is considered oversold relative to its 30-day fair value range of $0.74 to $0.97.
Technical Outlook: Technically, IVF is showing sideways momentum. Immediate support is located at $0.55, while resistance sits at $3.07. The stock is showing strong short-term momentum, up 364.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $20.00 (+646.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IVF is showing sideways momentum. Immediate support is located at $0.55, while resistance sits at $3.07. The stock is showing strong short-term momentum, up 364.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $20.00 (+646.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.74 -
$0.97
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+364.5%)
- BULLISH: Trading 646.3% below Wall St target ($20.00)
- WARNING: Recommendation downgraded due to 176.3% overvaluation
Fair Price Analysis
30-Day Fair Range
$0.74 -
$0.97
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.55
Resistance Level
$3.07
Current Trend
Sideways
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.12
Wall Street Target
$20.00
(+646.3%)
Revenue Growth (YoY)
22.6%
Share & Embed Analysis
Last updated: March 30, 2026 8:29 AM ET
Data refreshes hourly during market hours. Next update: 9:29 AM
Data refreshes hourly during market hours. Next update: 9:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IVF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Matthew K Szot
SELL
4 shares
2025-12-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 56 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 48 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 56 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 58 HOLD |